Sarvestani Soroush T, Stunden H James, Behlke Mark A, Forster Samuel C, McCoy Claire E, Tate Michelle D, Ferrand Jonathan, Lennox Kim A, Latz Eicke, Williams Bryan R G, Gantier Michael P
Centre for Cancer Research, MIMR-PHI Institute of Medical Research, Clayton, Victoria 3168, Australia Department of Molecular and Translational Science, Monash University, Clayton, Victoria 3168, Australia.
Institute of Innate Immunity, Biomedical Center, University Hospitals Bonn, Bonn 53127, Germany.
Nucleic Acids Res. 2015 Jan;43(2):1177-88. doi: 10.1093/nar/gku1343. Epub 2014 Dec 24.
Anti-microRNA (miRNA) oligonucleotides (AMOs) with 2'-O-Methyl (2'OMe) residues are commonly used to study miRNA function and can achieve high potency, with low cytotoxicity. Not withstanding this, we demonstrate the sequence-dependent capacity of 2'OMe AMOs to inhibit Toll-like receptor (TLR) 7 and 8 sensing of immunostimulatory RNA, independent of their miRNA-targeting function. Through a screen of 29 AMOs targeting common miRNAs, we found a subset of sequences highly inhibitory to TLR7 sensing in mouse macrophages. Interspecies conservation of this inhibitory activity was confirmed on TLR7/8 activity in human peripheral blood mononuclear cells. Significantly, we identified a core motif governing the inhibitory activity of these AMOs, which is present in more than 50 AMOs targeted to human miRNAs in miRBaseV20. DNA/locked nucleic acids (LNA) AMOs synthesized with a phosphorothioate backbone also inhibited TLR7 sensing in a sequence-dependent manner, demonstrating that the off-target effects of AMOs are not restricted to 2'OMe modification. Taken together, our work establishes the potential for off-target effects of AMOs on TLR7/8 function, which should be taken into account in their therapeutic development and in vivo application.
带有2'-O-甲基(2'OMe)残基的抗微小RNA(miRNA)寡核苷酸(AMO)常用于研究miRNA功能,且能高效发挥作用,细胞毒性低。尽管如此,我们证明了2'OMe AMO具有序列依赖性能力,可抑制Toll样受体(TLR)7和8对免疫刺激RNA的感应,这与其靶向miRNA的功能无关。通过对29种靶向常见miRNA的AMO进行筛选,我们在小鼠巨噬细胞中发现了一部分对TLR7感应具有高度抑制作用的序列。在人类外周血单核细胞中,这种抑制活性在TLR7/8活性上的种间保守性得到了证实。重要的是,我们确定了一个控制这些AMO抑制活性的核心基序,在miRBaseV20中,超过50种靶向人类miRNA的AMO中都存在该基序。用硫代磷酸酯骨架合成的DNA/锁核酸(LNA)AMO也以序列依赖的方式抑制TLR7感应,这表明AMO的脱靶效应并不局限于2'OMe修饰。综上所述,我们的工作确定了AMO对TLR7/8功能产生脱靶效应的可能性,在其治疗开发和体内应用中应予以考虑。